📌 Key Takeaways
- On May 6, 2026, the 52nd Korean Society for Laser Medicine and Surgery (KSLS) Spring International Conference was held at COEX Seoul, attracting over 5,000 physicians from Korea and abroad
- Korean botulinum toxin manufacturer Medytox set up the largest exhibition booth, showcasing two products: Coretox and Innotox
- The spotlight was on the concept of “botulinum toxin that can be combined with energy devices like HIFU and RF”—signaling that combination treatments delivering multiple effects in a single visit are becoming mainstream in Korean aesthetic medicine in 2026
“Can you do botulinum toxin and HIFU on the same day?” Until just a few years ago, this was a combination that made many physicians cautious.
But in Korea in 2026, a new generation of botulinum toxin products designed specifically for same-day combination with energy devices is drawing major attention at academic conferences.
INDEX
What Is the Korean Society for Laser Medicine and Surgery?
The Korean Society for Laser Medicine and Surgery (KSLS) is an academic organization focused on laser and energy-based devices in dermatology and aesthetic medicine. It holds international conferences twice a year.Korean aesthetic medicine often leads global trends, and techniques or protocols presented at KSLS conferences typically spread to Japan and other countries within 1-2 years.
Two Products Showcased by Medytox—What’s New?
What Is “Botulinum Toxin × Device Combination Therapy”?
The most notable message at this exhibition was that “Innotox is suitable for combination with energy devices.”
HIFU (High-Intensity Focused Ultrasound) delivers focused ultrasound energy to deep skin layers, causing thermal coagulation to achieve lifting effects. Well-known devices include Ultherapy and Shrink. RF (Radio Frequency) uses electromagnetic waves to heat skin from within, stimulating collagen production.
HIFU and RF are heat-based treatments that temporarily sensitize the skin post-procedure. Traditionally, physicians were cautious about performing botulinum toxin and HIFU on the same day.However, with new liquid-form and pure-component botulinum toxin formulations, research suggests this combination may be safer, enabling “completion of lifting + wrinkle reduction in a single visit”—a key goal of combination therapy protocols.
What 5,000+ Attendees Reveal About Korea’s “Learning Culture”
Over 5,000 physicians attended this conference—far exceeding Korea’s total number of board-certified dermatologists (approximately 2,950). This means many non-dermatologist physicians also participated.
Korea has a deeply rooted culture of physicians actively seeking the latest techniques in aesthetic medicine, with academic conferences functioning as practical technology update venues. This is one reason Korean aesthetic medicine leads globally.
The trend from this exhibition is clear: the keyword for Korean aesthetic medicine in 2026 is “optimization of combination therapy”—pursuing protocols that combine botulinum toxin, fillers, HIFU, and RF to deliver maximum results in a single visit.In Japan and other markets, patient inquiries about “receiving botulinum toxin and HIFU on the same day” are increasing, but feasibility depends on which formulation is used.
Asking your physician “Can you propose a botulinum toxin-device combination treatment?” may be the gateway to more efficient aesthetic medicine. However, always defer to your physician’s judgment on which combination suits your individual case.
Summary
- The KSLS Spring Conference (May 6, 2026) attracted over 5,000 physicians
- Medytox showcased Coretox (pure-component) and Innotox (liquid-form, device-compatible) in its largest booth
- “Botulinum toxin × HIFU/RF combination therapy” is emerging as a major trend in Korean aesthetic medicine in 2026
- Impact on Japan and other markets expected within 1-2 years—“availability of combination therapy proposals” may become a new criterion for clinic selection
Frequently Asked Questions
Sources
Seoul Economic Daily, “Medytox Showcases Aesthetic Medical Portfolio at Korean Dermatology Conference,” May 6, 2026
